News & Insights

News & Insights

< Back to Bio
Icon close orange Seth H. Lundy

Insight 30 results

Client Alert

November 19, 2019
General Counsels Decision Tree for Investigations of Life Sciences Companies

Client Alert

October 17, 2019
HHS Issues Proposed Rule to Update Anti-Kickback Statute Safe Harbors – What Does it Mean for Life Sciences Companies?

Client Alert

May 14, 2019
CMS Issues Final Rule Requiring the Disclosure of Drug List Prices in Direct-to-Consumer Television Ads

Client Alert

April 22, 2019
Congress Acts to Eliminate MDRP Misclassification

Client Alert

February 4, 2019
HHS Proposes Rule Challenging Drug Manufacturer Rebates to PBMs and Payors

Thought Leadership

January 13, 2019
New King & Spalding Report Analyzes Latest Healthcare Industry Trends

Client Alert

January 9, 2019
AdvaMed Updates Code of Ethics on Interactions with U.S. Health Care Professionals

Newsletter

July 16, 2018
Health Headlines – July 16, 2018

Client Alert

May 14, 2018
Trump Administration Releases 'Blueprint' to Address Drug Prices

Client Alert

March 7, 2018
FDA Issues Final Rule and Guidance Creating New Standards for the Acceptance of Data Obtained from Clinical Investigations Conducted Outside of the United States in Support of IDE and Device Marketing Applications

Client Alert

February 8, 2018
2017 Year in Review: State Laws Target Pharma Manufacturers

Client Alert

April 21, 2017
New York Institutes New Medicaid Drug Price Control Measures